Drugs / NPT200-11
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02606682 | Jul 2015 → Feb 2016 | — | Neuropore Therapies Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPT200-11 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02606682 ↗ |
| Route | Oral | “Single doses of NPT200-11capsules, orally administered” NCT02606682 ↗ |